Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
initial public offering
Pharma
Hansa eyes US listing ahead of FDA verdict on Idefirix
With the FDA expected to decide on its kidney transplant drug before year-end, Hansa Biopharma is mulling its stock listing options in the U.S.
Fraiser Kansteiner
Aug 24, 2026 2:45pm
Veradermics locks in $256M IPO, shares spike
Feb 5, 2026 10:01am
Visen Pharmaceuticals files for $86M IPO in Hong Kong
Mar 21, 2025 7:05am
AstraZeneca, Takeda, BioNTech—Fierce Pharma Asia
Nov 10, 2023 8:05am
Schott has carved out a standalone business for its pharma unit
Aug 1, 2022 3:14pm
Hansoh, J&J, Brii and more—Fierce Pharma Asia
Oct 22, 2021 5:46am
